跳至主要内容
临床试验/JPRN-UMIN000007923
JPRN-UMIN000007923已完成2 期

on-resectable colorectal liver metastases treated with cetuximab induction toward liver R0 resection trial - NEXTO

Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo0 个研究点目标入组 50 人开始时间: 2012年5月11日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Prior local therapy for liver metastases (2) Severe comorbidity (3) A past history of drug allergy (needs continuation therapy) (4) A past history of Interstitial lung disease (5) Patients who has not recovered from previous cancer treatment to less than Grade 1 toxicity (6) Fully recovered from surgical treatment within 4 weeks before registration (7) Received widespread radiation therapy within 6 weeks before registration (8) Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval (9) Severe infectious disease (10) Pleural effusion, ascites fluid and the pericardial fluid needing treatment (11) Watery diarrhea (watery colostomy output without trouble during patient's daily living is allowed) (12) Chronic systemic treatment of corticosteroid (13) Bleeding tendency, coagulation disorder, abnormality of coagulation factor, or administered anticoagulant (14) HBsAg positive, HCV-Ab positive or HIV positive (15) Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test (16) Psychological disorder (17) Considered not appropriate for surgery (18) Patients who are judged inappropriate for the entry into the study by the investigator

研究者

发起方
Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo

相似试验